Kustikova Olga S, Geiger Hartmut, Li Zhixiong, Brugman Martijn H, Chambers Stuart M, Shaw Chad A, Pike-Overzet Karin, de Ridder Dick, Staal Frank J T, von Keudell Gottfried, Cornils Kerstin, Nattamai Kalpana Jekumar, Modlich Ute, Wagemaker Gerard, Goodell Margaret A, Fehse Boris, Baum Christopher
Department of Experimental Hematology, Hannover Medical School, Germany.
Blood. 2007 Mar 1;109(5):1897-907. doi: 10.1182/blood-2006-08-044156. Epub 2006 Nov 21.
Evidence from model organisms and clinical trials reveals that the random insertion of retrovirus-based vectors in the genome of long-term repopulating hematopoietic cells may increase self-renewal or initiate malignant transformation. Clonal dominance of nonmalignant cells is a particularly interesting phenotype as it may be caused by the dysregulation of genes that affect self-renewal and competitive fitness. We have accumulated 280 retrovirus vector insertion sites (RVISs) from murine long-term studies resulting in benign or malignant clonal dominance. RVISs (22.5%) are located in or near (up to 100 kb [kilobase]) to known proto-oncogenes, 49.6% in signaling genes, and 27.9% in other or unknown genes. The resulting insertional dominance database (IDDb) shows substantial overlaps with the transcriptome of hematopoietic stem/progenitor cells and the retrovirus-tagged cancer gene database (RTCGD). RVISs preferentially marked genes with high expression in hematopoietic stem/progenitor cells, and Gene Ontology revealed an overrepresentation of genes associated with cell-cycle control, apoptosis signaling, and transcriptional regulation, including major "stemness" pathways. The IDDb forms a powerful resource for the identification of genes that stimulate or transform hematopoietic stem/progenitor cells and is an important reference for vector biosafety studies in human gene therapy.
来自模式生物和临床试验的证据表明,基于逆转录病毒的载体随机插入长期重建造血细胞的基因组中,可能会增加自我更新或引发恶性转化。非恶性细胞的克隆优势是一种特别有趣的表型,因为它可能是由影响自我更新和竞争适应性的基因失调引起的。我们从小鼠长期研究中积累了280个逆转录病毒载体插入位点(RVISs),这些研究导致了良性或恶性克隆优势。RVISs(22.5%)位于已知原癌基因内部或附近(最多100 kb[千碱基]),49.6%位于信号基因中,27.9%位于其他或未知基因中。由此产生的插入优势数据库(IDDb)与造血干/祖细胞的转录组和逆转录病毒标记的癌症基因数据库(RTCGD)有大量重叠。RVISs优先标记在造血干/祖细胞中高表达的基因,基因本体论显示与细胞周期控制、凋亡信号传导和转录调控相关的基因过度表达,包括主要的“干性”途径。IDDb为鉴定刺激或转化造血干/祖细胞的基因提供了强大的资源,是人类基因治疗中载体生物安全性研究的重要参考。